XML 28 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2022
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:          
Net loss (1) $ (119,872) $ (225,428) $ (401,905) [1] $ (33,077) [1] $ (24,266) [1]
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization     424 343 235
Claims amortization expense 41,708 153,560 266,929 164 125
Paid in kind interest 34,744 80,947 145,321 27,023 20,843
Change in fair value of derivatives     9,613    
Deferred income taxes (531) (531) (531)    
Share based compensation     20,055    
Change in fair value of warrant liability     2,870    
PPP loan forgiveness       (1,043) (44)
Realized gain on equity securities       (201) (18)
Gain on debt extinguishment     (63,367)    
Unrealized losses on investments—short position         279
Change in operating assets and liabilities:          
Accounts receivable (918) (7,664) (6,195)    
Affiliate receivable [1]     1,645 801 (3,346)
Affiliate payable [1]     (25,430) 6,225 5,670
Prepaid expenses and other assets     (27,604) 1 (9)
Commission payable     80    
Accounts payable and accrued liabilities     (2,291) 2,013 268
Deferred service fee income     (249)   249
Net cash used in operating activities (60,912) (70,764) (80,635) 2,249 (14)
Cash flows from investing activities:          
Additions to property, plant, and equipment     (2,984) (481) (330)
Additions to intangible assets     (2,700) (150)  
Proceeds from sale of equity securities       4,450 1,273
Purchases of equity securities       (4,056) (1,255)
Proceeds from short sale of short positions         1,298
Purchase of securities to cover short position       (1,770)  
Net cash used in investing activities (3,015) (4,563) (5,684) (2,007) 986
Cash flows from financing activities:          
Proceeds from Business Combination     12,009    
Transaction costs incurrred for the Business Combination     (49,638) (7,973)  
Proceeds from related party loan [1]     125,759    
Issuance of common stock     9,188    
Issuance of temporary equity     2,417    
Contributions from members       227 8,524
Distributions to members       (2,711)  
Proceeds from debt financing         1,086
Net cash provided by (used in) financing activities 98,728 99,351 99,735 (10,457) 9,610
Increase (decrease) in cash and cash equivalents and restricted cash     13,416 (10,215) 10,582
Cash and cash equivalents and restricted cash at beginning of year $ 1,664 $ 1,664 1,664 11,879 1,297
Cash and cash equivalents and restricted cash at end of period     15,080 1,664 11,879
Supplemental disclosure of non-cash investing and financing activities:          
Purchase of intangible asset financed by note payable       83,805  
Purchase of intangible asset through issuance of Class A common stokc     10,963    
Purchase of intangible asset in accrued expenses     51,167    
Payment of professional fees through issuance of Class A common stock     1,618    
Transaction costs incurred included in accounts payable and accrued liabilities     $ 29,681    
Cash paid during the period for:          
Interest       $ 23 $ 43
[1] Balances include related party transactions. See Note 14, Related Party, for further details.